Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Cholangiocarcinoma: anatomical location-dependent clinical, prognostic, and genetic disparities.

Hang H, Jeong S, Sha M, Kong D, Xi Z, Tong Y, Xia Q.

Ann Transl Med. 2019 Dec;7(23):744. doi: 10.21037/atm.2019.12.37.

2.

[Effect of utilization of child health services on the nutrition and growth status of infants in poor rural areas in Sichuan and Gansu Province].

Sun C, Meng S, Wang Q, Ye R, Wu Y, Cao M, Zhou H.

Wei Sheng Yan Jiu. 2019 Sep;48(5):745-750. Chinese.

PMID:
31601324
3.

Correlates of School Children's Handwashing: A Study in Tibetan Primary Schools.

Sun C, Wang Q, Poudel Adhikari S, Ye R, Meng S, Wu Y, Mao Y, Raat H, Zhou H.

Int J Environ Res Public Health. 2019 Sep 3;16(17). pii: E3217. doi: 10.3390/ijerph16173217.

4.

Does Donor Allograft Microsteatosis Matter? Comparison of Outcomes in Liver Transplantation With a Propensity-Matched Cohort.

Sha M, Jeong S, Xia Q.

Liver Transpl. 2019 Nov;25(11):1723-1724. doi: 10.1002/lt.25624. Epub 2019 Sep 16. No abstract available.

PMID:
31424625
5.

Neuroendocrine regulation of cholangiocarcinoma: A status quo review.

Sha M, Cao J, Sun HY, Tong Y, Xia Q.

Biochim Biophys Acta Rev Cancer. 2019 Aug;1872(1):66-73. doi: 10.1016/j.bbcan.2019.05.005. Epub 2019 May 30. Review.

PMID:
31152820
6.

Tumor-associated lymphangiogenesis predicts unfavorable prognosis of intrahepatic cholangiocarcinoma.

Sha M, Jeong S, Wang X, Tong Y, Cao J, Sun HY, Xia L, Xu N, Xi ZF, Zhang JJ, Kong XN, Xia Q.

BMC Cancer. 2019 Mar 8;19(1):208. doi: 10.1186/s12885-019-5420-z.

7.

Unravel a neuroactive sHA sulfation pattern with neurogenesis activity by a library of defined oligosaccharides.

Yao W, Chen M, Dou X, Jin H, Zhang X, Zhu Y, Sha M, Liu Z, Meng X, Zhang L, Zhu S, Li Z.

Eur J Med Chem. 2019 Feb 1;163:583-596. doi: 10.1016/j.ejmech.2018.12.004. Epub 2018 Dec 4.

PMID:
30557831
8.

Semisynthesis of Chondroitin Sulfate E Tetrasaccharide from Hyaluronic Acid.

Yao W, Zhu Y, Zhang X, Sha M, Meng X, Li Z.

J Org Chem. 2018 Nov 16;83(22):14069-14077. doi: 10.1021/acs.joc.8b01987. Epub 2018 Oct 25.

PMID:
30359032
9.

Expression of VEGFR-3 in intrahepatic cholangiocarcinoma correlates with unfavorable prognosis through lymphangiogenesis.

Sha M, Jeong S, Chen XS, Tong Y, Cao J, Sun HY, Xia L, Xu N, Wang X, Han LZ, Xi ZF, Zhang JJ, Kong XN, Xia Q.

Int J Biol Sci. 2018 Jul 27;14(10):1333-1342. doi: 10.7150/ijbs.26045. eCollection 2018.

10.

Isolation of cancer-associated fibroblasts and its promotion to the progression of intrahepatic cholangiocarcinoma.

Sha M, Jeong S, Qiu BJ, Tong Y, Xia L, Xu N, Zhang JJ, Xia Q.

Cancer Med. 2018 Sep;7(9):4665-4677. doi: 10.1002/cam4.1704. Epub 2018 Jul 31.

11.

Impact of viral hepatitis B status on outcomes of intrahepatic cholangiocarcinoma: a meta-analysis.

Jeong S, Luo G, Wang ZH, Sha M, Chen L, Xia Q.

Hepatol Int. 2018 Jul;12(4):330-338. doi: 10.1007/s12072-018-9881-y. Epub 2018 Jun 26. Review.

PMID:
29947010
12.

Construction of Hyaluronic Tetrasaccharide Clusters Modified Polyamidoamine siRNA Delivery System.

Ma Y, Sha M, Cheng S, Yao W, Li Z, Qi XR.

Nanomaterials (Basel). 2018 Jun 14;8(6). pii: E433. doi: 10.3390/nano8060433.

13.

Antiviral therapy improves survival in patients with HBV infection and intrahepatic cholangiocarcinoma undergoing liver resection: Novel concerns.

Sha M, Jeong S, Xia Q.

J Hepatol. 2018 Jun;68(6):1315-1316. doi: 10.1016/j.jhep.2018.01.039. Epub 2018 Feb 20. No abstract available.

PMID:
29475065
14.

Prognostic Impact of Cirrhosis in Patients with Intrahepatic Cholangiocarcinoma following Hepatic Resection.

Jeong S, Gao L, Tong Y, Xia L, Xu N, Sha M, Zhang J, Kong X, Gu J, Xia Q.

Can J Gastroenterol Hepatol. 2017;2017:6543423. doi: 10.1155/2017/6543423. Epub 2017 Nov 12.

15.

Risk factors and survival outcomes of biliary complications after adult-to-adult living donor liver transplantation.

Jeong S, Wang X, Wan P, Sha M, Zhang J, Xia L, Tong Y, Luo Y, Xia Q.

United European Gastroenterol J. 2017 Nov;5(7):997-1006. doi: 10.1177/2050640616688994. Epub 2017 Jan 18.

16.

Current status of liver transplantation for cholangiocarcinoma.

Jeong S, Sha M, Xia Q.

Liver Transpl. 2018 Mar;24(3):440. doi: 10.1002/lt.24974. Epub 2018 Feb 9. No abstract available.

17.

Risk stratification system to predict recurrence of intrahepatic cholangiocarcinoma after hepatic resection.

Jeong S, Cheng Q, Huang L, Wang J, Sha M, Tong Y, Xia L, Han L, Xi Z, Zhang J, Kong X, Gu J, Xia Q.

BMC Cancer. 2017 Jul 3;17(1):464. doi: 10.1186/s12885-017-3464-5.

18.
19.

Comparison of the ability of the PDD-ICG clearance test, CTP, MELD, and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis.

Cheng XP, Zhao J, Chen Y, Meng FK, Xu B, Yu HW, Meng QH, Liu YM, Zhang SB, Meng S, Zhang JY, Zhang JY, Duan ZP, Zheng SJ.

Eur J Gastroenterol Hepatol. 2016 Apr;28(4):444-8. doi: 10.1097/MEG.0000000000000538.

20.

Synthesis, Crystal Structure, and Photoelectric Properties of a New Layered Bismuth Oxysulfide.

Meng S, Zhang X, Zhang G, Wang Y, Zhang H, Huang F.

Inorg Chem. 2015 Jun 15;54(12):5768-73. doi: 10.1021/acs.inorgchem.5b00436. Epub 2015 May 27.

PMID:
26016620

Supplemental Content

Loading ...
Support Center